BIOLOGICAL SIGNIFICANCE OF CIMETIDINE SULFOXIDE COMPLEXES WITH COPPER(II) AND ZINC(II) IONS DURING CIMETIDINE TREATMENT

被引：7

作者：

FREIJANES, E ^{[1
]}

BERTHON, G ^{[1
]}

机构：

[1] UNIV TOULOUSE 3,CTR TECHNOL BIOMED,INSERM,SC 13,CHIM BIOINORGAN LAB,RUE TRENTE 6,F-31400 TOULOUSE,FRANCE

来源：

INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY | 1986年 / 124卷 / 03期

关键词：

D O I：

10.1016/S0020-1693(00)85864-8

中图分类号：

O61 [无机化学];

学科分类号：

070301 ; 081704 ;

摘要：

引用

页码：141 / 147

页数：7

共 28 条

[1] AN ASSESSMENT OF THE PHYSIOLOGICAL SIGNIFICANCE OF CIMETIDINE INTERACTIONS WITH COPPER AND ZINC IN BIOFLUIDS AS BASED ON THE COMPUTER-SIMULATED DISTRIBUTION OF THE INVOLVED COMPLEXES AT THERAPEUTIC LEVELS OF THE DRUG [J].

AKRIVOS, F ;

BLAIS, MJ ;

HOFFELT, J ;

BERTHON, G .

AGENTS AND ACTIONS, 1984, 15 (5-6) :649-659

[2]

[Anonymous], TRACE ELEMENTS HUMAN

[3] TRACE-METAL REQUIREMENTS IN TOTAL PARENTERAL-NUTRITION .6. A QUANTITATIVE STUDY OF THE COPPER(II) HISTIDINE TERNARY COMPLEXES WITH LEUCINE, GLUTAMIC-ACID, METHIONINE, TRYPTOPHAN AND ALANINE, AND FINAL EVALUATION OF THE DAILY DOSES OF COPPER AND ZINC SPECIFIC TO A NUTRITIVE MIXTURE OF A GIVEN COMPOSITION [J].

BERTHON, G ;

PIKTAS, M ;

BLAIS, MJ .

INORGANICA CHIMICA ACTA-BIOINORGANIC CHEMISTRY, 1984, 93 (03) :117-130

[4]

BOASSON M, 1980, REV RHUM, V47, P580

[5] METAL-BINDING BY PHARMACEUTICALS .1. COPPER(II) AND ZINC(II) INTERACTIONS FOLLOWING ETHAMBUTOL ADMINISTRATION [J].

COLE, A ;

MAY, PM ;

WILLIAMS, DR .

AGENTS AND ACTIONS, 1981, 11 (03) :296-305

[6]

COLE NJ, 1981, PHARM INT, V2, P63

[7] METAL-BINDING BY PHARMACEUTICALS .2. INTERACTIONS OF CA(II), CU(II), FE(II), MG(II), MN(II) AND ZN(II) WITH THE INTRACELLULAR HYDROLYSIS PRODUCTS OF THE ANTI-TUMOR AGENT ICRF159 AND ITS INACTIVE HOMOLOG ICRF192 [J].

HUANG, ZX ;

MAY, PM ;

QUINLAN, KM ;

WILLIAMS, DR ;

CREIGHTON, AM .

AGENTS AND ACTIONS, 1982, 12 (04) :536-542

[8] NO DETECTABLE CONCENTRATIONS OF OXMETIDINE BUT MEASURABLE CONCENTRATIONS OF CIMETIDINE IN CEREBROSPINAL-FLUID (CSF) DURING MULTIPLE DOSE TREATMENT [J].

JONSSON, KA ;

ERIKSSON, SE ;

KAGEVI, I ;

NORLANDER, B ;

BODEMAR, G ;

WALAN, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 17 (06) :781-782

[9] POTENTIOMETRIC STUDY OF IMIDAZOLE COMPLEXATION WITH PROTON, CO(II), NI(II), CU(II), ZN(II), CD(II) IONS UNDER PHYSIOLOGICAL CONDITIONS [J].

KAYALI, A ;

BERTHON, G .

BIOELECTROCHEMISTRY AND BIOENERGETICS, 1979, 6 (03) :337-348

[10] THE PHARMACOKINETICS OF CIMETIDINE AND ITS SULFOXIDE METABOLITE IN PATIENTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION [J].

LARSSON, R ;

ERLANSON, P ;

BODEMAR, G ;

WALAN, A ;

BERTLER, A ;

FRANSSON, L ;

NORLANDER, B .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 13 (02) :163-170

← 1 2 3 →